Sr. Director, Market Access at Cognoa
Andy brings 11 years of pharmaceutical industry experience, specifically bridging technology with business needs. Andy has focused on optimizing operational systems and building consistencies in business processes to build powerful analytics platforms. He transitioned his more technically focused background into market access strategy and contract operations. Combining the technical with pharma, Andy recently decided to join the expanding industry of using digital interventions to diagnose and treat disease. Andy has been instrumental in defining market access launch strategies for multiple digital therapeutics companies and building the infrastructure to manage this new modality.